secwatch / observer
8-K filed July 8, 2026, 4:00 PM ET ticker MGNX CIK 0001125345
leadership confidence high sentiment neutral materiality 0.20

MacroGenics board member Karen Ferrante resigns effective Sept 1, 2026

MACROGENICS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Karen Ferrante

director
MGNX · MACROGENICS INC
Effective
2026-09-01
Filed
July 8, 2026, 4:00 PM ET
On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Karen Ferrante resigned as director at MACROGENICS INC.

Action
resigned
Role
director
Exact text from the filing
On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.
View on SEC.gov

MACROGENICS INC filing history →

Source: SEC EDGAR
accession 0001125345-26-000047
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.